Literature DB >> 23319227

Botulinum toxin in the treatment of post-traumatic headache - case study.

Marcela Lippert-Grüner1.   

Abstract

Pharmacotherapy of acute post-traumatic tension headaches consists of analgesics and non-steroidal anti-inflammatory drugs (NSAIDs). Treatment of chronic tension-type head-aches consists mainly of tricyclic antidepressants; local injection of botulinum toxin is one of the comparatively newer therapeutic options. No data on the treatment of post-traumatic headaches with botulinum toxin exist. A 62-year-old woman with a history of major traumatic brain injury five years previously developed chronic tension-type headaches of an oppressive nature. The results of treatment with oral medication were not satisfactory. The patient was treated with local injections of 22 IU Botox® into the frontalis muscle and corrugator supercilii muscle. After only five days, the headaches had improved and after ten days the patient was free of symptoms even when under stress. Sufficiently large-scale clinical studies are now required to better evaluate the effects of botulinum toxin on post-traumatic headaches.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23319227     DOI: 10.5114/ninp.2012.32109

Source DB:  PubMed          Journal:  Neurol Neurochir Pol        ISSN: 0028-3843            Impact factor:   1.621


  5 in total

Review 1.  Insights and advances in post-traumatic headache: research considerations.

Authors:  Teshamae S Monteith; David Borsook
Journal:  Curr Neurol Neurosci Rep       Date:  2014-02       Impact factor: 5.081

Review 2.  Interventional Treatment for Post-traumatic Headache.

Authors:  Francis X Conidi
Journal:  Curr Pain Headache Rep       Date:  2016-06

3.  The efficiency of botulinum toxin type A for the treatment of masseter muscle pain in patients with temporomandibular joint dysfunction and tension-type headache.

Authors:  Malgorzata Pihut; Ewa Ferendiuk; Michal Szewczyk; Katarzyna Kasprzyk; Mieszko Wieckiewicz
Journal:  J Headache Pain       Date:  2016-03-24       Impact factor: 7.277

4.  The Role of Onabotulinum Toxin Type A in the Management of Chronic Non-migraine Headaches.

Authors:  Cassie Jia; Scott Lucchese; Fang Zhang; Raghav Govindarajan
Journal:  Front Neurol       Date:  2019-09-19       Impact factor: 4.003

5.  Preclinical assessment of onabotulinumtoxinA for the treatment of mild traumatic brain injury-related acute and persistent post-traumatic headache.

Authors:  Edita Navratilova; Janice Oyarzo; Trent Anderson; Ron S Broide; Sudhakar R Subramaniam; Edwin J Vazquez-Cintron; Mitchell F Brin; Todd J Schwedt; David W Dodick; Frank Porreca
Journal:  Cephalalgia       Date:  2022-05-11       Impact factor: 6.075

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.